The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels

Daniel W. Fitzgerald, Karl Bezak, Oksana Ocheretina, Cynthia Riviere, Thomas C. Wright, Ginger L. Milne, Xi Kathy Zhou, Baoheng Du, Kotha Subbaramaiah, Erin Byrt, Matthew L. Goodwin, Arash Rafii Tabrizi, Andrew J. Dannenberg

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV-1) infection causes chronic inflammation. COX-2-derived prostaglandin E 2 (PGE 2) has been linked to both inflammation and carcinogenesis. We hypothesized that HIV-1 could induce COX-2 in cervical tissue and increase systemic PGE 2 levels and that these alterations could play a role in AIDS-related cervical cancer. Levels of cervical COX-2 mRNA and urinary PGE-M, a biomarker of systemic PGE 2 levels, were determined in 17 HIV-negative women with a negative cervical human papilloma virus (HPV) test, 18 HIV-infected women with a negative HPV test, and 13 HIV-infected women with cervical HPV and high-grade squamous intraepithelial lesions on cytology. Cervical COX-2 levels were significantly associated with HIV and HPV status (P = 0.006 and 0.002, respectively). Median levels of urinary PGE-M were increased in HIV-infected compared with uninfected women (11.2 vs. 6.8 ng/mg creatinine, P = 0.02). Among HIV-infected women, urinary PGE-M levels were positively correlated with plasma HIV-1 RNA levels (P = 0.003). Finally, levels of cervical COX-2 correlated with urinary PGE-M levels (P = 0.005). This study shows that HIV-1 infection is associated with increased cervical COX-2 and elevated systemic PGE 2 levels. Drugs that inhibit the synthesis of PGE 2 may prove useful in reducing the risk of cervical cancer or systemic inflammation in HIV-infected women.

Original languageEnglish
Pages (from-to)34-40
Number of pages7
JournalCancer Prevention Research
Volume5
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Papillomaviridae
Prostaglandins E
Coinfection
HIV
HIV-1
Inflammation
Uterine Cervical Neoplasms
HIV Infections
Cell Biology
Creatinine
Carcinogenesis
Acquired Immunodeficiency Syndrome
Biomarkers
RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fitzgerald, D. W., Bezak, K., Ocheretina, O., Riviere, C., Wright, T. C., Milne, G. L., ... Dannenberg, A. J. (2012). The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels. Cancer Prevention Research, 5(1), 34-40. https://doi.org/10.1158/1940-6207.CAPR-11-0496

The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels. / Fitzgerald, Daniel W.; Bezak, Karl; Ocheretina, Oksana; Riviere, Cynthia; Wright, Thomas C.; Milne, Ginger L.; Zhou, Xi Kathy; Du, Baoheng; Subbaramaiah, Kotha; Byrt, Erin; Goodwin, Matthew L.; Tabrizi, Arash Rafii; Dannenberg, Andrew J.

In: Cancer Prevention Research, Vol. 5, No. 1, 01.2012, p. 34-40.

Research output: Contribution to journalArticle

Fitzgerald, DW, Bezak, K, Ocheretina, O, Riviere, C, Wright, TC, Milne, GL, Zhou, XK, Du, B, Subbaramaiah, K, Byrt, E, Goodwin, ML, Tabrizi, AR & Dannenberg, AJ 2012, 'The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels', Cancer Prevention Research, vol. 5, no. 1, pp. 34-40. https://doi.org/10.1158/1940-6207.CAPR-11-0496
Fitzgerald, Daniel W. ; Bezak, Karl ; Ocheretina, Oksana ; Riviere, Cynthia ; Wright, Thomas C. ; Milne, Ginger L. ; Zhou, Xi Kathy ; Du, Baoheng ; Subbaramaiah, Kotha ; Byrt, Erin ; Goodwin, Matthew L. ; Tabrizi, Arash Rafii ; Dannenberg, Andrew J. / The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels. In: Cancer Prevention Research. 2012 ; Vol. 5, No. 1. pp. 34-40.
@article{f8cb9f5dc79240328abcee0c3e7ce07d,
title = "The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels",
abstract = "Human immunodeficiency virus (HIV-1) infection causes chronic inflammation. COX-2-derived prostaglandin E 2 (PGE 2) has been linked to both inflammation and carcinogenesis. We hypothesized that HIV-1 could induce COX-2 in cervical tissue and increase systemic PGE 2 levels and that these alterations could play a role in AIDS-related cervical cancer. Levels of cervical COX-2 mRNA and urinary PGE-M, a biomarker of systemic PGE 2 levels, were determined in 17 HIV-negative women with a negative cervical human papilloma virus (HPV) test, 18 HIV-infected women with a negative HPV test, and 13 HIV-infected women with cervical HPV and high-grade squamous intraepithelial lesions on cytology. Cervical COX-2 levels were significantly associated with HIV and HPV status (P = 0.006 and 0.002, respectively). Median levels of urinary PGE-M were increased in HIV-infected compared with uninfected women (11.2 vs. 6.8 ng/mg creatinine, P = 0.02). Among HIV-infected women, urinary PGE-M levels were positively correlated with plasma HIV-1 RNA levels (P = 0.003). Finally, levels of cervical COX-2 correlated with urinary PGE-M levels (P = 0.005). This study shows that HIV-1 infection is associated with increased cervical COX-2 and elevated systemic PGE 2 levels. Drugs that inhibit the synthesis of PGE 2 may prove useful in reducing the risk of cervical cancer or systemic inflammation in HIV-infected women.",
author = "Fitzgerald, {Daniel W.} and Karl Bezak and Oksana Ocheretina and Cynthia Riviere and Wright, {Thomas C.} and Milne, {Ginger L.} and Zhou, {Xi Kathy} and Baoheng Du and Kotha Subbaramaiah and Erin Byrt and Goodwin, {Matthew L.} and Tabrizi, {Arash Rafii} and Dannenberg, {Andrew J.}",
year = "2012",
month = "1",
doi = "10.1158/1940-6207.CAPR-11-0496",
language = "English",
volume = "5",
pages = "34--40",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels

AU - Fitzgerald, Daniel W.

AU - Bezak, Karl

AU - Ocheretina, Oksana

AU - Riviere, Cynthia

AU - Wright, Thomas C.

AU - Milne, Ginger L.

AU - Zhou, Xi Kathy

AU - Du, Baoheng

AU - Subbaramaiah, Kotha

AU - Byrt, Erin

AU - Goodwin, Matthew L.

AU - Tabrizi, Arash Rafii

AU - Dannenberg, Andrew J.

PY - 2012/1

Y1 - 2012/1

N2 - Human immunodeficiency virus (HIV-1) infection causes chronic inflammation. COX-2-derived prostaglandin E 2 (PGE 2) has been linked to both inflammation and carcinogenesis. We hypothesized that HIV-1 could induce COX-2 in cervical tissue and increase systemic PGE 2 levels and that these alterations could play a role in AIDS-related cervical cancer. Levels of cervical COX-2 mRNA and urinary PGE-M, a biomarker of systemic PGE 2 levels, were determined in 17 HIV-negative women with a negative cervical human papilloma virus (HPV) test, 18 HIV-infected women with a negative HPV test, and 13 HIV-infected women with cervical HPV and high-grade squamous intraepithelial lesions on cytology. Cervical COX-2 levels were significantly associated with HIV and HPV status (P = 0.006 and 0.002, respectively). Median levels of urinary PGE-M were increased in HIV-infected compared with uninfected women (11.2 vs. 6.8 ng/mg creatinine, P = 0.02). Among HIV-infected women, urinary PGE-M levels were positively correlated with plasma HIV-1 RNA levels (P = 0.003). Finally, levels of cervical COX-2 correlated with urinary PGE-M levels (P = 0.005). This study shows that HIV-1 infection is associated with increased cervical COX-2 and elevated systemic PGE 2 levels. Drugs that inhibit the synthesis of PGE 2 may prove useful in reducing the risk of cervical cancer or systemic inflammation in HIV-infected women.

AB - Human immunodeficiency virus (HIV-1) infection causes chronic inflammation. COX-2-derived prostaglandin E 2 (PGE 2) has been linked to both inflammation and carcinogenesis. We hypothesized that HIV-1 could induce COX-2 in cervical tissue and increase systemic PGE 2 levels and that these alterations could play a role in AIDS-related cervical cancer. Levels of cervical COX-2 mRNA and urinary PGE-M, a biomarker of systemic PGE 2 levels, were determined in 17 HIV-negative women with a negative cervical human papilloma virus (HPV) test, 18 HIV-infected women with a negative HPV test, and 13 HIV-infected women with cervical HPV and high-grade squamous intraepithelial lesions on cytology. Cervical COX-2 levels were significantly associated with HIV and HPV status (P = 0.006 and 0.002, respectively). Median levels of urinary PGE-M were increased in HIV-infected compared with uninfected women (11.2 vs. 6.8 ng/mg creatinine, P = 0.02). Among HIV-infected women, urinary PGE-M levels were positively correlated with plasma HIV-1 RNA levels (P = 0.003). Finally, levels of cervical COX-2 correlated with urinary PGE-M levels (P = 0.005). This study shows that HIV-1 infection is associated with increased cervical COX-2 and elevated systemic PGE 2 levels. Drugs that inhibit the synthesis of PGE 2 may prove useful in reducing the risk of cervical cancer or systemic inflammation in HIV-infected women.

UR - http://www.scopus.com/inward/record.url?scp=84862907776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862907776&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-11-0496

DO - 10.1158/1940-6207.CAPR-11-0496

M3 - Article

VL - 5

SP - 34

EP - 40

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 1

ER -